Inspire Medical Systems, Inc. (INSP): Price and Financial Metrics
INSP Price/Volume Stats
| Current price | $234.19 | 52-week high | $330.00 |
| Prev. close | $233.93 | 52-week low | $123.27 |
| Day low | $232.77 | Volume | 255,600 |
| Day high | $237.03 | Avg. volume | 531,475 |
| 50-day MA | $205.33 | Dividend yield | N/A |
| 200-day MA | $202.88 | Market Cap | 7.10B |
INSP Stock Price Chart Interactive Chart >
Inspire Medical Systems, Inc. (INSP) Company Bio
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is based in Maple Grove, Minnesota.
Latest INSP News From Around the Web
Below are the latest news stories about INSPIRE MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate INSP as an investment opportunity.
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of DirectorsCompany adds further expertise in medical device industry R&D, regulatory affairs and commercializationMINNEAPOLIS, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the appointment of Myriam J. Curet, M.D., as an independent Director to its Board, effective December 21, 202 |
15 Best Fast Growth Stocks to Buy NowIn this article, we will take a look at the 15 best fast growth stocks to buy now. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Best Fast Growth Stocks to Buy Now. Vanguard Growth ETF is one of the most famous growth focused […] |
Inspire Medical Systems (INSP) Fell on Concerns about Weight Loss DrugChartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Value Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Information technology and industrials were the top-performing sectors in the Carillon Chartwell Small Cap Growth Fund, with alpha production coming from well-chosen stocks. […] |
Inspire Medical Systems (INSP) Fell on Growing Use of Weight Loss DrugWasatch Global Investors, an investment management firm, released its “Wasatch Small Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Stocks fell broadly in the quarter as investors worried about the consequences of rising interest rates and a possible recession. During the quarter, the strategy declined but […] |
Inspire Medical Systems, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceMINNEAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. Inspire is scheduled to present at 10:30 a.m. Eastern Time. The presentation will be accessible via |
INSP Price Returns
| 1-mo | 12.45% |
| 3-mo | 10.05% |
| 6-mo | 55.28% |
| 1-year | -13.15% |
| 3-year | -2.89% |
| 5-year | 342.95% |
| YTD | 15.12% |
| 2023 | -19.24% |
| 2022 | 9.48% |
| 2021 | 22.31% |
| 2020 | 153.46% |
| 2019 | 75.64% |
Continue Researching INSP
Want to do more research on Inspire Medical Systems Inc's stock and its price? Try the links below:Inspire Medical Systems Inc (INSP) Stock Price | Nasdaq
Inspire Medical Systems Inc (INSP) Stock Quote, History and News - Yahoo Finance
Inspire Medical Systems Inc (INSP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...